Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT06114121

Intrathecal Morphine vs. Intrathecal Morphine and Regional Anesthesia After Cesarean Section.

Comparing Intrathecal Morphine and Erector Spinae Plane Regional Anesthesia Against Intrathecal Morphine Alone for Post-Cesarean Section Pain

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Miami · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The objective of the study is to optimize post-operative analgesia and improve patient satisfaction while reducing total opioid consumption after cesarean section

Conditions

Interventions

TypeNameDescription
PROCEDUREerector spinae plane block (ESP)nerve block for abdominal pain. administered once immediately prior to spinal anesthetic standard of care.
DRUGDuramorph100 micrograms (mcg) of morphine administered in the spinal medications one time.
DRUGRopivacaineRopivacaine 0.5% between 20-40 milliliters will be administered once in the ESP block (in the spine) depending on patient weight to keep under the maximum dose.
DRUGBupivacaine InjectionBupivacaine 0.75% 1.4-1.7 milliliters (10-12 milligrams) spinal medication. administered one time.

Timeline

Start date
2024-07-10
Primary completion
2024-09-10
Completion
2024-09-10
First posted
2023-11-02
Last updated
2024-09-19

Regulatory

Source: ClinicalTrials.gov record NCT06114121. Inclusion in this directory is not an endorsement.